Citra 50mg tramadol - Tramadol Tablets Description
In Asia, Tramadol is used mainly to address labor pains. In Mexico, Tramadol is freely available in a form where it is mixed with paracetamol.
In this form, no prescription is needed. What is the impact of Schedule IV placement? Schedule IV drugs have an accepted medical treatment use in the US and abuse of these drugs might lead to limited dependence or lower dependence compared to drugs listed in Schedule III. Schedule IV drugs are controlled and monitored and have limits on how many times their prescriptions can be refilled within a six-month period Currently, drugs under this schedule can be refilled a maximum of five times every six-month period.
Drug Interactions Considering the fact that Tramadol has demonstrated serotonin and norepinephrine reuptake inhibiting qualities, patients who are taking selective serotonin reuptake inhibitors like Zoloft, Prozac, and other compounds, selective norepinephrine reuptake inhibitors like Effexor, monoamine oxidase inhibitors like isocarboxazid, phenelzine, selegiline and other compounds, tricyclic antidepressants like amitriptyline, amitriptylinoxide, butriptyline, and others must consult with their physician about the dosage of tramadol to take.
In some of these situations, Tramadol might be ruled out completely due to strong drug interactions. Similarly, if the patient is taking strong opioid-based based compounds like morphine, fentanyl, methadone, and oxycodone, the patient's doctor needs to be advised to see if Tramadol is a feasible treatment option. Finally, if a patient is over 75 years of age or is a minor or is suffering from reduced liver or kidney functions, the patient's physician must be advised.
What are the adverse effects of Tramadol? For the majority of patients taking Tramadol, there are no adverse effects. However, in small percentages of Tramadol users, the following side effects have been observed.
The following list is in the order of severity with the most common side effects listed first. The most common side effects of Tramadol are drowsiness, nausea, dizziness, constipation, headache, vomiting, diarrhea, dry mouth, fatigue, indigestion, and, in a very small number of patients, seizures. In addition to the side effects above, there is also a body of observed side effects for people taken off Tramadol too quickly. These range from nervous 'thrashing' in the patient's bed and uncontrolled tremors and muscle contractions.
Other fairly rare side effects include electrical shock-like sensations, a 'buzzing' effect, and anxiety. Some observers note that these effects are somewhat similar to those of patients experiencing withdrawal from Effexor.
In terms of sexual performance, Tramadol has been observed to delay ejaculation in some instances as well as produce other sexual dysfunctions. Patients who are taking SSRI medications require extra scrutiny since these medications might interact with Tramadol in such a way as to trigger potentially fatal serotonin toxicity. The most severe side effect of Tramadol are seizures.
Thankfully, this occurs only in very rare instances. Seizures have been reported in the cases of individuals who take very large doses mg oral or mg intravenous of Tramadol. In very rare cases, persons who take much lower doses experience seizures. There is a growing body of research that indicates that Tramadol should not be prescribed for patients who have uncontrolled epilepsy.
Who are most at risk of seizures? Tramadol takers who are between the gages of 25 and 54 years old, patients who exceed four tramadol prescriptions, and individuals who have a record of head trauma injury, stroke, or alcohol abuse. Can patients become physically dependent on Tramadol? All in all, it is harder to become physically depend or addicted to Tramadol compared to other opiate-based medications. In fact, this drug's habit-forming potential is low enough for the US Drug Enforcement Agency to leave it off its list of controlled substances.
With that said, addiction to Tramadol is still possible. Patients who take low dosages for Tramadol on a short-term basis are less likely to develop physical dependence than those who take the medication over a long period of time at high dosages. These latter patients can exhibit withdrawal symptoms when taken off Tramadol.
You should not breast-feed while you are taking this medicine. Do not give this medication to anyone younger than 16 years old without the advice of a doctor. Ultram ER should not be given to anyone younger than 18 years old.
Rybix ODT may contain phenylalanine. Talk to your doctor before using this form of tramadol if you have phenylketonuria PKU. How should I take tramadol? Take tramadol exactly as prescribed. Follow all directions on your prescription label.
Never take in larger amounts, or for longer than prescribed. Tell your doctor if the medicine seems to stop working as well in relieving your pain. Stop taking all other around-the-clock narcotic pain medications when you start taking tramadol.
Tramadol can be taken with or without food, but take it the same way each time. Never crush or break a tramadol pill to inhale the powder or mix it into a liquid to inject the drug into your vein.
This practice has resulted in death with the misuse of tramadol and similar prescription drugs. To take tramadol orally disintegrating tablets Rybix ODT: Keep the tablet in its blister pack until you are ready to take it. Use dry hands to remove the tablet and place it in your mouth.
Do not swallow the tablet whole. Allow it to dissolve in your mouth without chewing. If desired, you may drink liquid to help swallow the dissolved tablet. If you use the tramadol extended-release tablet, the tablet shell may pass into your stools bowel movements.
This is normal and does not mean that you are not receiving enough of the medicine. Do not stop using tramadol suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to safely stop using this medicine. Store at room temperature away from moisture and heat. Keep track of the amount of medicine used from each new bottle. Tramadol is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription. What happens if I miss a dose?
Since tramadol is used for pain, you are not likely to miss a dose. Skip any missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose. What happens if I overdose? Seek emergency medical attention or call the Poison Help line. Therefore, individuals who are ultra-rapid metabolizers should not use tramadol. Neonatal Opioid Withdrawal Syndrome Prolonged use of tramadol during pregnancy can result in withdrawal in the neonate.
Neonatal opioid withdrawal syndrome, unlike opioid withdrawal syndrome in adults, may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. Observe newborns for signs of neonatal opioid withdrawal syndrome and manage accordingly. Risks of Interactions with Drugs Affecting Cytochrome P Isoenzymes The effects of concomitant use or discontinuation of cytochrome P 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors on levels of tramadol and M1 from tramadol are complex.
A decrease in M1 exposure in patients who have developed physical dependence to tramadol, may result in signs and symptoms of opioid withdrawal and reduced efficacy.
The effect of increased tramadol levels may be an increased risk for serious adverse events including seizures and serotonin syndrome. Discontinuation of a concomitantly used cytochrome P 2D6 inhibitor may result in a decrease in tramadol plasma levels and an increase in active metabolite M1 levels, which could increase or prolong adverse reactions related to opioid toxicity and may cause potentially fatal respiratory depression.
Cytochrome P 3A4 Interaction The concomitant use of tramadol with cytochrome P 3A4 inhibitors, such as macrolide antibiotics e. The concomitant use of tramadol with all cytochrome P 3A4 inducers or discontinuation of a cytochrome P 3A4 inhibitor may result in lower tramadol levels.
This may be associated with a decrease in efficacy, and in some patients, may result in signs and symptoms of opioid withdrawal. Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Profound sedation, respiratory depression, coma, and death may result from the concomitant use of tramadol with benzodiazepines or other CNS depressants e. Because of these risks, reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate.
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioid analgesics alone. If the decision is made to prescribe a benzodiazepine or other CNS depressant concomitantly with an opioid analgesic, prescribe the lowest effective dosages and minimum durations of concomitant use.
In patients already receiving an opioid analgesic, prescribe a lower initial dose of the benzodiazepine or other CNS depressant than indicated in the absence of an opioid, and titrate based on clinical response. If an opioid analgesic is initiated in a patient already taking a benzodiazepine or other CNS depressant, prescribe a lower initial dose of the opioid analgesic, and titrate based on clinical response.
Follow patients closely for signs and symptoms of respiratory depression and sedation. Advise both patients and caregivers about the risks of respiratory depression and sedation when tramadol is used with benzodiazepines or other CNS depressants including alcohol and illicit drugs. Advise patients not to drive or operate heavy machinery until the effects of concomitant use of the benzodiazepine or other CNS depressant have been determined. Serotonin Syndrome Risk Cases of serotonin syndrome, a potentially life-threatening condition, have been reported with the use of tramadol, particularly during concomitant use with serotonergic drugs.
Serotonergic drugs include selective serotonin reuptake inhibitors SSRIs , serotonin and norepinephrine reuptake inhibitors SNRIs , tricyclic antidepressants TCAs , triptans, 5- HT3 receptor antagonists, drugs that affect the serotonergic neurotransmitter system e. This may occur within the recommended dosage range. Serotonin syndrome symptoms may include mental status changes e. The onset of symptoms generally occurs within several hours to a few days of concomitant use, but may occur later than that.
Discontinue tramadol if serotonin syndrome is suspected. Increased Risk of Seizure Seizures have been reported in patients receiving tramadol within the recommended dosage range. Spontaneous post-marketing reports indicate that seizure risk is increased with doses of tramadol above the recommended range. Concomitant use of tramadol increases the seizure risk in patients taking: Risk of seizure may also increase in patients with epilepsy, those with a history of seizures, or in patients with a recognized risk for seizure such as head trauma, metabolic disorders, alcohol and drug withdrawal, CNS infections.
In tramadol overdose, naloxone administration may increase the risk of seizure. Suicide Risk Do not prescribe tramadol for patients who are suicidal or addiction-prone. Adrenal Insufficiency Cases of adrenal insufficiency have been reported with opioid use, more often following greater than one month of use.
Presentation of adrenal insufficiency may include non-specific symptoms and signs including nausea, vomiting, anorexia, fatigue, weakness, dizziness, and low blood pressure. If adrenal insufficiency is suspected, confirm the diagnosis with diagnostic testing as soon as possible. If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids.
Wean the patient off of the opioid to allow adrenal function to recover and continue corticosteroid treatment until adrenal function recovers. Other opioids may be tried as some cases reported use of a different opioid without recurrence of adrenal insufficiency. The information available does not identify any particular opioids as being more likely to be associated with adrenal insufficiency.
Life-Threatening Respiratory Depression in Patients with Chronic Pulmonary Disease or in Elderly, Cachectic, or Debilitated Patients The use of tramadol in patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment is contraindicated.
Patients with Chronic Pulmonary Disease: Elderly, Cachectic, or Debilitated Patients: Life-threatening respiratory depression is more likely to occur in elderly, cachectic, or debilitated patients because they may have altered pharmacokinetics or altered clearance compared to younger, healthier patients see WARNINGS.
Monitor such patients closely, particularly when initiating and titrating tramadol and when tramadol is given concomitantly with other drugs that depress respiration see WARNINGS.
Alternatively, consider the use of non-opioid analgesics in these patients. Severe Hypotension Tramadol may cause severe hypotension including orthostatic hypotension and syncope in ambulatory patients.
There is increased risk in patients whose ability to maintain blood pressure has already been compromised by a reduced blood volume or concurrent administration of certain CNS depressant drugs e.
Monitor these patients for signs of hypotension after initiating or titrating the dosage of tramadol. In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure.
Avoid the use of tramadol in patients with circulatory shock. Monitor such patients for signs of sedation and respiratory depression, particularly when initiating therapy with tramadol.
Opioids may also obscure the clinical course in a patient with a head injury. Avoid the use of tramadol in patients with impaired consciousness or coma. The tramadol in tramadol may cause spasm of the sphincter of Oddi. Opioids may cause increases in serum amylase. Monitor patients with biliary tract disease, including acute pancreatitis for worsening symptoms. Anaphylaxis and Other Hypersensitivity Reactions Serious and rarely fatal anaphylactoid reactions have been reported in patients receiving therapy with tramadol.
When these events do occur it is often following the first dose. Other reported allergic reactions include pruritus, hives, bronchospasm, angioedema, toxic epidermal necrolysis and Stevens-Johnson syndrome. If anaphylaxis or other hypersensitivity occurs, stop administration of tramadol immediately, discontinue tramadol permanently, and do not rechallenge with any formulation of tramadol. Risks of Driving and Operating Machinery Tramadol may impair the mental or physical abilities needed to perform potentially hazardous activities such as driving a car or operating machinery.
Warn patients not to drive or operate dangerous machinery unless they are tolerant to the effects of tramadol and know how they will react to the medication.
Precautions Renal and Hepatic Disease Impaired renal function results in a decreased rate and extent of excretion of tramadol and its active metabolite, M1. Metabolism of tramadol and M1 is reduced in patients with advanced cirrhosis of the liver. With the prolonged half-life in these conditions, achievement of steady-state is delayed, so that it may take several days for elevated plasma concentrations to develop.
Instruct patients not to share tramadol with others and to take steps to protect tramadol from theft or misuse. Life-Threatening Respiratory Depression Inform patients of the risk of life-threatening respiratory depression, including information that the risk is greatest when starting tramadol or when the dosage is increased, and that it can occur even at recommended dosages see WARNINGS. Advise patients how to recognize respiratory depression and to seek medical attention if breathing difficulties develop.
Serotonin Syndrome Inform patients that opioids could cause a rare but potentially life-threatening condition resulting from concomitant administration of serotonergic drugs. Warn patients of the symptoms of serotonin syndrome, and to seek medical attention right away if symptoms develop. MAOI Interaction Inform patients not to take tramadol while using any drugs that inhibit monoamine oxidase.
Adrenal Insufficiency Inform patients that opioids could cause adrenal insufficiency, a potentially life- threatening condition. Adrenal insufficiency may present with non-specific symptoms and signs such as nausea, vomiting, anorexia, fatigue, weakness, dizziness, and low blood pressure.
Important Administration Instructions Instruct patients how to properly take tramadol. If patients have been receiving treatment with tramadol for more than a few weeks and cessation of therapy is indicated, counsel them on the importance of safely tapering the dose as abrupt discontinuation of the medication could precipitate withdrawal symptoms. Hypotension Inform patients that tramadol may cause orthostatic hypotension and syncope.
Citra no imprint?
Metabolism 50mg is extensively metabolized after oral administration by a number of pathways, citra 50mg tramadol, including CYP2D6 and CYP3A4, as well citra by conjugation of parent and metabolites. Perhaps a large part of this versatility is due to market demand arising from the perception that Tramadol is less susceptible to abuse. Consider these risks when prescribing or dispensing tramadol. Still, patients should consider the version of the Physicians' Desk Reference which contains some warnings from Tramadol's main manufacturer. These withdrawal symptoms are like those of withdrawal symptoms for opiate-like or opioid-based pain relievers. The plasma clearance was 6. Life-Threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression has been reported with tramadol use of opioids, citra 50mg tramadol, even when used as recommended. Therefore, individuals who are ultra-rapid citra should not use tramadol. The potential for these risks should 50mg, however, citra 50mg tramadol, prevent the proper management of pain in any given patient. Precautions Renal and Hepatic Disease Impaired renal function results in a decreased rate and extent of excretion of tramadol and its active metabolite, Tramadol. Nursing Mothers Tramadol is subject to the same polymorphic metabolism as codeine, with ultra-rapid metabolizers of CYP2D6 substrates being potentially exposed to life-threatening levels of the active metabolite O-desmethyltramadol M1.